Aurora Cannabis (NASDAQ:ACB) Gains EU Plant Variety Rights for Cannabis Varieties

EDMONTON, AB — January 20, 2026 — Leads & Copy — Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) has been granted community plant variety rights by the EU’s Community Plant Variety Office for two of its proprietary cannabis varieties.

This achievement strengthens the company’s intellectual property portfolio and reinforces its commitment to innovation and cannabis genetics excellence.

The EU’s Community Plant Variety Office granted the rights for Cannabis sativa L varieties named SOT20R07-007 (Farm Gas™) and ACB21T044 (Sourdough™). Bred in Canada through Aurora’s advanced breeding and phenotyping programs, these varieties and their traits are the result of the company’s research expertise and scientific standards.

Farm Gas™ and Sourdough™ are core products available to medical patients in Germany, Poland, UK, Canada, and Australia. Both cultivars are recognized for their strong patient and consumer appeal – including high potency and desirable aromas and bud structure – as well as for their consistency, and strong performance traits.

According to Lana Culley, VP of Innovation and International Operations for Aurora, the EU plant variety rights are a direct recognition of the cannabis genetics work underway at Aurora Coast R&D facility. Culley added that the protection strengthens Aurora’s global genetics portfolio and ensures that its high-quality, differentiated varieties can consistently reach patients and consumers worldwide. Aurora remains committed to advancing its breeding program and developing genetics that set new standards in cannabis cultivation.

The Community Plant Variety Rights give Aurora exclusive control over the commercial production and sale of these varieties throughout the European Union’s 27 member states for the duration of the protection period. With these rights in the EU, as well as existing rights in Canada and other territories, Aurora can commercialize its cultivars globally while protecting investments in science and innovation. Aurora’s cultivars are grown in its own network of cultivation sites, as well as by partners and licensees around the world.

Aurora’s genetics platform supports the company’s ability to deliver consistent, reliable, and premium products. The protection of these varieties enhances Aurora’s competitive position in Europe.

Aurora Cannabis Inc. is headquartered in Edmonton, Alberta. The company serves the medical and consumer markets across Canada, Europe, Australia and New Zealand. Aurora’s adult-use brand portfolio includes Drift®, San Raf®, Daily Special™, Tasty’s™, Being® and Greybeard®. Medical cannabis brands include MedReleaf®, CanniMed®, Aurora® and Whistler Medical Marijuana Corporation®, as well as international brands, Pedanios®, IndiMed™ and CraftPlant™. Aurora also has a controlling interest in Bevo Farms Ltd.

Aurora’s common shares trade on the NASDAQ and TSX under the symbol “ACB”.

Contact:
Aurora Cannabis Inc.

Source: Aurora Cannabis Inc.

×

Welcome!

Biotech Reporter is the source most up-to-date real-time, direct-from-source News Tips and Story Leads.

By Subscribing you will receive Daily Biotech Update each day at 9:30 am ET (Market Open) in your inbox and you can unsubscribe any time.